Genetics, diagnosis and future treatment strategies for primary ciliary dyskinesia

Mary Leigh Anne Daniels, Peadar G Noone

Open source

DOI
10.1517/21678707.2015.989212
Published
2014-11-29
Container
Expert Opinion on Orphan Drugs
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1517/21678707.2015.989212,
  title = {Genetics, diagnosis and future treatment strategies for primary ciliary dyskinesia},
  author = {Mary Leigh Anne Daniels and Peadar G Noone},
  year = {2014},
  journal = {Expert Opinion on Orphan Drugs},
  doi = {10.1517/21678707.2015.989212},
  url = {https://doi.org/10.1517/21678707.2015.989212}
}

RIS

TY  - JOUR
TI  - Genetics, diagnosis and future treatment strategies for primary ciliary dyskinesia
AU  - Mary Leigh Anne Daniels
AU  - Peadar G Noone
PY  - 2014
JO  - Expert Opinion on Orphan Drugs
DO  - 10.1517/21678707.2015.989212
UR  - https://doi.org/10.1517/21678707.2015.989212
ER  - 

APA

Daniels, M. L. A., & Noone, P. G. (2014). Genetics, diagnosis and future treatment strategies for primary ciliary dyskinesia. Expert Opinion on Orphan Drugs. https://doi.org/10.1517/21678707.2015.989212

Source records